PICCINNI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 3.866
EU - Europa 3.327
AS - Asia 2.458
AF - Africa 230
SA - Sud America 197
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.087
Nazione #
US - Stati Uniti d'America 3.828
IT - Italia 955
GB - Regno Unito 798
CN - Cina 710
SG - Singapore 701
VN - Vietnam 517
DE - Germania 440
SE - Svezia 324
HK - Hong Kong 199
RU - Federazione Russa 178
IN - India 163
UA - Ucraina 145
BR - Brasile 143
FR - Francia 133
IE - Irlanda 111
ZA - Sudafrica 79
CI - Costa d'Avorio 77
NL - Olanda 58
EE - Estonia 56
JP - Giappone 55
TG - Togo 42
BE - Belgio 30
AR - Argentina 26
CA - Canada 24
FI - Finlandia 24
JO - Giordania 20
TW - Taiwan 15
AT - Austria 13
CH - Svizzera 13
ID - Indonesia 13
NG - Nigeria 13
MX - Messico 11
SC - Seychelles 11
HR - Croazia 9
LB - Libano 8
CO - Colombia 7
EC - Ecuador 7
PL - Polonia 7
SA - Arabia Saudita 7
BD - Bangladesh 6
GR - Grecia 6
KR - Corea 6
LT - Lituania 6
AU - Australia 5
CL - Cile 5
IR - Iran 5
TH - Thailandia 5
TR - Turchia 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
ES - Italia 4
PH - Filippine 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
UZ - Uzbekistan 4
EG - Egitto 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
DZ - Algeria 1
EU - Europa 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MT - Malta 1
MV - Maldive 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
Totale 10.087
Città #
Southend 701
Singapore 454
Chandler 361
Fairfield 338
Ashburn 330
Santa Clara 311
Dong Ket 199
Wilmington 197
Princeton 193
Hong Kong 190
Ann Arbor 150
Woodbridge 147
Houston 143
Seattle 115
Beijing 111
Dublin 106
Cambridge 98
Ho Chi Minh City 94
Bologna 90
Boardman 86
Jacksonville 86
Westminster 78
Abidjan 77
Nanjing 76
Dallas 75
Padova 75
Rome 66
Los Angeles 55
Hanoi 54
Medford 48
Shenyang 43
Tokyo 43
Lomé 42
Saint Petersburg 39
Milan 38
Berlin 34
Bremen 34
Buffalo 34
Dearborn 34
Mülheim 33
Brussels 28
Nanchang 27
Jinan 26
Redwood City 26
Changsha 25
Olalla 23
San Diego 23
Redondo Beach 22
Hebei 21
Helsinki 21
San Venanzo 21
Amman 20
Frankfurt am Main 20
Hefei 19
New York 18
Florence 17
Guangzhou 17
Munich 17
Palermo 17
Tianjin 17
Shanghai 16
Zhengzhou 16
Falls Church 15
Hangzhou 15
Turin 15
Haikou 14
Abeokuta 13
Taipei 13
Kunming 12
London 12
Norwalk 12
Phoenix 12
Bari 11
Biella 11
Jiaxing 11
Ningbo 11
São Paulo 11
Toronto 11
Yubileyny 11
Lanzhou 10
Messina 10
Chicago 9
Redmond 9
Torino 9
Trieste 9
Bühl 8
Ferrero 8
Fuzhou 8
Portsmouth 8
Bern 7
Biên Hòa 7
Cagliari 7
Cesena 7
Düsseldorf 7
Montesilvano Marina 7
Nuremberg 7
Brooklyn 6
Caserta 6
Da Nang 6
Frankfurt Am Main 6
Totale 6.306
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 517
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 275
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 228
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 228
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 220
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 191
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 189
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 185
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 174
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 170
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 167
Social and clinical descriptors of antipsychotic prescription 164
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 163
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 162
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 161
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 155
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 153
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 152
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 145
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 145
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 142
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 142
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 136
Aderenza al trattamento con Bifosfonati: studio di coorte retrospettivo su database amministrativi dell’Emilia Romagna 133
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 132
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 129
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 128
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 128
Prescription patterns of oral bisphosphonates in Italian patients with osteoporosis 126
Infarto del miocardio, edema maculare e fratture associate ai glitazoni: analisi del database di segnalazione spontanea FDA_AERS 124
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 122
Determinanti demografici, clinici ed organizzativi dell’aderenza alla poli-terapia dopo infarto miocardico acuto 120
Determinanti demografici, clinici ed organizzativi dell'aderenza alla poli-terapia dopo infarto miocardico acuto 120
A project for monitoring disease modifying drug prescriptions for multiple sclerosis in Emilia Romagna 119
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 119
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 118
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 118
Impact of notoriety bias on reporting of pancreatitis with antidiabetics: the case of exenatide 117
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 117
Pioglitazone-associated bladder cancer: the contribution of spontaneous reporting analysis on the basis of FDA_AERS database 116
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 116
Profili di utilizzo dei farmaci antipsicotici nei centri salute mentale della AUSL di Bologna: determinanti clinici e sociali 116
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence 116
Burden of community-acquired pneumonia in Italian general practice 113
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 112
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 111
Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction 111
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 110
Aderenza alla terapia antidepressiva in Emilia-Romagna 109
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 109
Progetto europeo di confronto dell'uso dei farmaci 108
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 108
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 107
Psychiatrists’ Use of Shared Decision Making in the Treatment of Psychosis: The “Farmaci and Famiglie” Project in Bologna 105
Three years of experience: the Italian registry and safety data update 104
Natalizumab: a country-based surveillance program 104
La rimborsabilità di memantina - il trilemma di Münchausen 103
Glucagon-like peptide 1-based drugs and pancreatic safety. 103
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database. 97
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 97
The key role of patient in the antipsychotic therapy: shared decision making, adherence and research 96
I rapporti tra medici, pazienti e familiari nella scelta delle terapie farmacologiche dei disturbi psichici: un’indagine presso il dipartimento di salute mentale della AUSL di Bologna 95
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 95
Drug-induced Progressive Multifocal Leukoencephalopathy: data mining of international spontaneous ADR report databases 91
L’uso dei farmaci in Italia. Rapporto nazionale anno 2011 88
The Italian Surveillance Program on Natalizumab 87
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 87
Monitoring the use of disease-modifying drugs in multiple sclerosis 86
VII Report Health Search Anno 2011/2012 83
Lack of adherence to oral bisphosphonates in Italian patients: prevalence and predictors 82
The Italian Natalizumab Registry: a 1-year follow-up 81
Drug-related Progressive Multifocal Leukoencephalopathy (PML): datamining of FDA_AERS (Adverse Event Reporting System) 81
Factors Influencing the Disproportional Association Between Triptans and Cerebrovascular Events Within the FDA_AERS Database: Causal Association or Reporting Bias? 81
Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions 81
Prescrizione di Entacapone nella Regione Emilia-Romagna 80
Healthcare of patients with immunoglobulin A nephropathy through a retrospective observational study of Italian administrative data 78
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 74
Use of disease-modifying drugs for multiple sclerosis in neurological centres of Emilia Romagna 71
Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases 70
Drug utilisation of antidepressants in Generai Practice: choice of drugs and adherence in an Italian region 65
Totale 10.261
Categoria #
all - tutte 26.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.751


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021644 0 0 0 0 0 56 30 45 54 47 58 354
2021/20221.466 153 66 69 105 127 93 28 87 45 98 356 239
2022/20231.598 195 199 116 212 88 116 40 108 261 64 142 57
2023/2024563 44 79 38 70 57 50 38 31 25 46 58 27
2024/20251.616 99 239 110 116 421 107 86 48 21 74 32 263
2025/20261.522 194 290 368 188 457 25 0 0 0 0 0 0
Totale 10.261